Found: 7
Select item for more details and to access through your institution.
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer.
- Published in:
- Oncogenesis, 2018, v. 7, n. 5, p. 1, doi. 10.1038/s41389-018-0052-8
- By:
- Publication type:
- Article
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24010-1
- By:
- Publication type:
- Article
Proline-rich acidic protein 1 ( PRAP1) is a novel interacting partner of MAD1 and has a suppressive role in mitotic checkpoint signalling in hepatocellular carcinoma.
- Published in:
- Journal of Pathology, 2014, v. 233, n. 1, p. 51, doi. 10.1002/path.4319
- By:
- Publication type:
- Article
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 70, doi. 10.1159/000531176
- By:
- Publication type:
- Article
Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025547
- By:
- Publication type:
- Article
Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00731-0
- By:
- Publication type:
- Article
Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
- Published in:
- Liver International, 2010, v. 30, n. 1, p. 65, doi. 10.1111/j.1478-3231.2009.02117.x
- By:
- Publication type:
- Article